HCA Healthcare raises FY23 EPS view to $17.25-$18.55 from $16.40-$17.60

Consensus $17.25. Raises FY23 revenue view to $62.5B-$64.5B from $61.5B-$63.5B, consensus $62.61B. Sees FY23 adjusted EBITDA $12.1B-$12.7B. The company said, "Capital expenditures for 2023, excluding acquisitions, are estimated to be approximately $4.6 billion. The Company’s 2023 guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding the impact of the COVID-19 pandemic as well as general economic conditions, including inflation, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets."